SP direction19 Sep 2022 20:07
So, i ask, where do we see AZN in 2022?
Do we see earnings tripling ( so MS & Jefferies think), though.
EPS without vaccines, grew 23% upto February this year.
On this note, i think AZN can rebound from here and continue to outperform the FTSE.
Let’s hope come November 10/11th we get more good news while SP.
I’m tempted to rebuy some GSK since i sold last year before split.
What’s other peoples opinions on these two matters?